Abstract
Human adenovirus proteinase (AVP), the first member of a new class of cysteine proteinases, is required for the synthesis of infectious virus. As such, it is an attractive target for proteinase inhibitors that act as antiviral agents. However, before potential inhibitors can be screened, a quick, sensitive, and quantitative assay for the enzyme is required. Here, methods for purification of a recombinant AVP expressed in Escherichia coli are presented and a fluorogenic substrate is designed, synthesized, and purified and then used in the development of a quick, sensitive, and quantitative assay for the enzyme. The reporting group in the substrate is Rhodamine 110, possibly the most detectable compound known. The substrate contains the proteinase consensus cleavage sequence (Leu-Arg-Gly-Gly). The synthesis and purification of (Leu-Arg-Gly-Gly-NH)2-Rhodamine is described. It is then used to develop assays with AVP and its various cofactors. The resultant assays are quite sensitive; enzyme activity at low nanomolar concentrations can readily be detected.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Weber, J. (1976) Genetic analysis of adenovirus type 2 III. Temperaturesensitivity of processing of viral proteins. J. Virol. 17, 462–471.
Hannan, C., Raptis, L. H., Dery, C. V., and Weber, J. (1983) Biological and structural studies with adenovirus type 2 temperature-sensitive mutant defective for uncoating. Intervirology 19, 213–223.
Mirza, A. and Weber, J. (1980) Infectivity and uncoating of adenovirus cores. Intervirology 13, 307–311.
Brown, M. T., McGrath, W. J., Toledo, D. L., and Mangel, W. F. (1996) Different modes of inhibition of human adenovirus proteinase, probably a cysteine proteinase, by bovine pancreatic trypsin inhibitor. FEBS Lett. 388, 233–237.
Greber, U. F., Webster, P., Weber, J., and Helenius, A. (1996) The role of the adenovirus protease in virus entry into cells. EMBO J. 15, 1766–1777.
Cotten, M. and Weber, J. M. (1995) The adenovirus proteinase is required for entry into host cells. Virology 213, 494–502.
Greber, U. F. (1998) Virus assembly and disassembly: the adenovirus cysteine protease as a trigger factor. Rev. Med. Virol. 8, 213–222.
Chen, P. H., Ornelles, D.A., and Shenk, T. (1993) The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells. J. Virol. 67, 3507–3514.
Brown, M. T., McBride, K. M., Baniecki, M. L., Reich, N. C., Marriott, G., and Mangel, W.F. (2002) Actin can act as a cofactor for a viral proteinase in the cleavage of the cytoskeleton. J. Biol. Chem. 277, 46,298–46,303.
Yeh-Kai, L., Akusjarvi, G., Alestrom, P., Pettersson, U., Tremblay, M., and Weber, J. (1983) Genetic identification of an endopeptidase encoded by the adenovirus genome. J. Mol. Biol. 167, 217–222.
Mangel, W. F., McGrath, W. J., Toledo, D.L., and Anderson, C. W. (1993) Viral DNA and a viral peptide can act as cofactors of adenovirus virion proteinase activity. Nature 361, 274–275.
Tihanyi, K., Bourbonniere, M., Houde, A., Rancourt, C., and Weber, J. M. (1993) Isolation and properties of adenovirus type 2 proteinase. J. Biol. Chem. 268, 1780–1785.
Anderson, C. W. (1993) Expression and purification of the adenovirus proteinase polypeptide and of a synthetic proteinase substrate. Protein Express. Purif. 4, 8–15.
Webster, A., Hay, R.T., and Kemp, G. (1993) The adenovirus protease is activated by a virus-coded disulphide-linked peptide. Cell 72, 97–104.
Webster, A. and Kemp, G. (1993) The active adenovirus protease is the intact L3 23K protein. J. Gen. Virol. 74, 1415–1420.
Mangel, W. F., Toledo, D. L., Brown, M. T., Martin, J.H., and McGrath, W. J. (1996) Characterization of three components of human adenovirus proteinase activity in vitro. J. Biol. Chem. 271, 536–543.
McGrath, W. J., Baniecki, M. L., Li, C., et al. (2001) Human adenovirus proteinase: DNA binding and stimulation of proteinase activity by DNA. Biochemistry 40, 13,237–13,245.
Brown, M.T. and Mangel, W. F. (2004) Interaction of actin and its 11-aminoacid C-terminal peptide as cofactors with the adenovirus proteinase. FEBS 563, 213–218.
Webster, A., Russell, S., Talbot, P., Russell, W.C., and Kemp, G. D. (1989) Characterization of the adenovirus proteinase: substrate specificity. J. Gen. Virol. 70, 3225–3234.
Leytus, S. P., Melhado, L.L., and Mangel, W. F. (1983) Rhodamine-based compounds as fluorogenic substrates for serine proteases. Biochem. J. 209, 299–307.
Mangel, W. F., Leytus, S.P., and Melhado, L. L. (1987) Novel Rhodamine derivatives as fluorogenic substrates. U.S. Patent 4,640,893 (February 1987).
Mangel, W. F., Leytus, S.P., and Melhado, L. L. (1985) Rhodamine derivatives as fluorogenic substrates forproteinases. U.S. Patent 4,557,862 (December 1985).
Leytus, S. P., Patterson, W.L., and Mangel, W. F. (1983) New class of sensitive, specific, and selective substrates for serine proteinases: fluorogenic, amino acid peptide derivatives of Rhodamine. Biochem. J. 215, 253–260.
Leytus, S. P., Toledo, D.L., and Mangel, W. F. (1984) Theory and experimental method for determining individual kinetic constants for fast-acting, irreversible, protease inhibitors. Biochim. Biophys. Acta 788, 74–86.
McGrath, W. J., Abola, A. P., Toledo, D. L., Brown, M.T., and Mangel, W. F. (1996) Characterization of human adenovirus proteinase activity in disrupted virus particles. Virology 217, 131–138.
Baniecki, M. L., McGrath, W. J., McWhirter, S. M., et al. (2001) Interaction of the human adenovirus proteinase with its eleven amino-acid cofactor pVIc. Biochemistry 40, 12,349–12,356.
Gill, S.G. and von Hippel, P. H. (1989) Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182, 319–326.
Bajpayee, N. S., McGrath, W.J., and Mangel, W. F. (2005) Interaction of the adenovirus proteinase with protein cofactors with high negative charge densities. Biochemistry 44, 8721–8729.
McGrath, W. J., Ding, J., Sweet, R.M., and Mangel, W. F. (1996) Preparation and crystallization of a complex between human adenovirus serotype 2 proteinase and its 11-amino-acid cofactor pVIc. J. Struct. Biol. 117, 77–79.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc, Totowa, NJ
About this protocol
Cite this protocol
Mangel, W.F., McGrath, W.J. (2007). Assay for the Adenovirus Proteinase. In: Wold, W.S.M., Tollefson, A.E. (eds) Adenovirus Methods and Protocols. Methods in Molecular Medicine™, vol 131. Humana Press. https://doi.org/10.1007/978-1-59745-277-9_19
Download citation
DOI: https://doi.org/10.1007/978-1-59745-277-9_19
Publisher Name: Humana Press
Print ISBN: 978-1-58829-901-7
Online ISBN: 978-1-59745-277-9
eBook Packages: Springer Protocols